Sign In
Buy ABMD
$381.02
+0 (+0%)
At Close: Mar 20, 2023
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Adamis Pharmaceuticals Corp (NASDAQ: ADMP)
Annexon...
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
12:00am, Friday, 24'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
Abiomed: Current Momentum Looks Sustainable After Year Of Controversy
06:12pm, Wednesday, 22'nd Jul 2020
Abiomed's share price has grown impressively since the March market sell-off, on solid sales and progress of its Impella heart pump product range.
FMS vs. ABMD: Which Stock Should Value Investors Buy Now?
03:40pm, Wednesday, 22'nd Jul 2020
FMS vs. ABMD: Which Stock Is the Better Value Option?
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
12:00am, Wednesday, 22'nd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 21)
ABIOMED, Inc. (NASDAQ: ABMD)
Assembly Biosciences Inc (NASDAQ: ASMB)
Bio-Rad Laboratories, Inc. (NYSE: BIO)...
Abiomed Gets FDA Nod for Data Streaming Via Impella Connect
12:19pm, Monday, 20'th Jul 2020
Abiomed's (ABMD) announcement of the FDA approval of one-way digital data streaming from the Impella Connect interface can boost patient outcomes further.
Harel Insurance Investments & Financial Services Ltd. Invests $225,000 in ABIOMED, Inc. (NASDAQ:ABMD)
06:20pm, Thursday, 16'th Jul 2020
Harel Insurance Investments & Financial Services Ltd. acquired a new stake in shares of ABIOMED, Inc. (NASDAQ:ABMD) during the 2nd quarter, according to the company in its most recent 13F filing with
Abiomed First Quarter Fiscal 2021 Earnings and Conference Call Notification
11:00am, Thursday, 16'th Jul 2020
Abiomed announced that on Thursday, August 6, 2020, the Company will release financial results for the first quarter of fiscal 2021.
De Amerikaanse Food and Drug Administration (FDA) heeft eenzijdige digitale datastreaming goedgekeurd tijdens patiëntenondersteuning door Abiomed’s (N
ABIOMED (NASDAQ:ABMD) Rating Increased to Positive at OTR Global
05:26am, Tuesday, 14'th Jul 2020
OTR Global upgraded shares of ABIOMED (NASDAQ:ABMD) to a positive rating in a research note released on Monday morning, The Fly reports. ABMD has been the subject of a number of other reports. SVB Lee
State of Alaska Department of Revenue Grows Position in ABIOMED, Inc. (NASDAQ:ABMD)
06:03am, Monday, 13'th Jul 2020
State of Alaska Department of Revenue boosted its stake in ABIOMED, Inc. (NASDAQ:ABMD) by 2.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owne
Did Hedge Funds Make The Right Call On ABIOMED, Inc. (ABMD) ?
11:38pm, Sunday, 12'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Short Interest in ABIOMED, Inc. (NASDAQ:ABMD) Declines By 13.6%
02:54am, Tuesday, 07'th Jul 2020
ABIOMED, Inc. (NASDAQ:ABMD) saw a large drop in short interest in the month of June. As of June 30th, there was short interest totalling 2,360,000 shares, a drop of 13.6% from the June 15th total of 2
Xenon Lights Market Trajectory & Analytics to 2027 - COVID-19 Updated - ResearchAndMarkets.com
12:00am, Tuesday, 07'th Jul 2020
The
